BioNTech to invest $43 mln in German facility for mRNA vaccine building block
Reuters· 6 日前BioNTech (22UAy.DE) will invest 40 million euros ($43 million) in a new facility in
Artificial Intelligence Opens The Door To More Effective Antibodies - Potential Applications ...
Forbes· 1 日前One of the major time hindrances to the development of monoclonal antibodies is one of the ...
雅虎香港 搜尋
- 12 個搜尋結果
